Skip to content
MedsAcross

Medicine

Zocor 20 mg tablet

Simvastatin · Oral · Organon
Available on requestPrescription onlyUS FDA

Zocor 20 mg tablet is a prescription medicine containing Simvastatin for oral use, marketed by Organon, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store between 41°F to 86°F (5°C to 30°C).

Key facts

Active ingredient (INN)
Simvastatin
Brand
Zocor
Strength
20 mg
Dosage form
Tablet
Route
Oral
Packs
30 tablets, 90 tablets
Marketing authorisation holder
Organon
Manufacturer
Organon
Origin register
US FDA, United States
Storage
Store between 41°F to 86°F (5°C to 30°C).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C10AA01 Simvastatin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 June 2021
Identifiers
RxCUI 104490, 104491, 152923 +3DailyMed set ID 8f55d5de-5a4f-4a39-8c84-c53976dd6af9NDC 78206-181Application NDA019766

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
30 tablet, film coated in 1 bottle78206-181-01Organon1 June 2021
90 tablet, film coated in 1 bottle78206-181-02Organon1 June 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 23 December 1991Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Simvastatin 20 mg tablet.

Compare 1

Other strengths and forms of Simvastatin

Clinical summary

Simvastatin is an HMG-CoA reductase inhibitor indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Simvastatin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Simvastatin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Zocor 20 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.